论文部分内容阅读
已知,对中国药典胰酶酪蛋白转化力测定终点管的判断,是观察不易求得一致而有争议的问题。82年上半年,行业内曾进行了胰酶优质产品评比,确也反映各地、各厂对终点管判断掌握不一。大家都希望对此能进行一些研讨,以便统一判断标准。胰酶是行业内的重点产品之一。近年来,还有相当数量的产品出口日本,供作胰血管舒缓素等的起始材料,其质量标准亦暂按中国药典控制酪蛋白转化力。因此,对胰酶酪蛋白转化力测定终点管判断的研讨,对
It is known that the determination of the end point tube of the Chinese Pharmacopoeia pancreatin casein conversion assay is not easy to find a consistent and controversial issue. In the first half of the year 82, quality appraisal of pancreatic enzymes was conducted in the industry. Indeed, it also reflected the different opinions of different factories and factories on judging the end point of tubes. We all hope that some discussions can be conducted on this point in order to unify the criteria for judgment. Trypsin is one of the key products in the industry. In recent years, there are a considerable number of products exported to Japan for the pancreas and other raw materials such as kallikrein, its quality standards are temporarily controlled by the Chinese Pharmacopoeia casein conversion. Therefore, tryptophan casein conversion assay to determine the end of the tube to determine the right